Status:
COMPLETED
Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy
Lead Sponsor:
University of Aarhus
Conditions:
Multifocal Motor Neuropathy
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the effect of subcutaneous administration of immunoglobulin compared to intravenous treatment, for multifocal motor neuropathy NB. ONLY RECRUITING FROM DENMAR...
Detailed Description
Introduction Intravenous immunoglobulin (IVIG) treatment is the only established treatment modality in Multifocal Motor Neuropathy (MMN). In order to maintain neuromuscular performance patients requir...
Eligibility Criteria
Inclusion
- \- Clinical diagnosis of multifocal motor neuropathy, supported by electrophysiological findings
Exclusion
- Other severe medical conditions
- Pregnancy and lactation
- Anti-coagulation therapy
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00268788
Start Date
August 1 2005
End Date
February 1 2008
Last Update
February 21 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital, Department of Neyrology
Aarhus, Denmark